UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000007935
Receipt No. R000009342
Scientific Title Qualitative evaluation of blood cultures and epidemiology of treatment of septicemia in Japanese hospitals
Date of disclosure of the study information 2012/05/12
Last modified on 2013/05/29

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Qualitative evaluation of blood cultures and epidemiology of treatment of septicemia in Japanese hospitals
Acronym Qualitative evaluation of blood cultures and epidemiology of treatment of septicemia in Japanese hospitals
Scientific Title Qualitative evaluation of blood cultures and epidemiology of treatment of septicemia in Japanese hospitals
Scientific Title:Acronym Qualitative evaluation of blood cultures and epidemiology of treatment of septicemia in Japanese hospitals
Region
Japan

Condition
Condition bacteremia
Classification by specialty
Infectious disease
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 The purposes of this research are the qualitative evaluation of the examination of blood culture examination, and the analysis of clinical information of BSIs.
Basic objectives2 Others
Basic objectives -Others Evaluation of catheter-related BSI (CRBSI )
Trial characteristics_1 Confirmatory
Trial characteristics_2
Developmental phase Not applicable

Assessment
Primary outcomes *Evaluation of the situation regarding blood culture collection (two sets rate, contamination rate)
*Evaluation of catheter-related BSI (CRBSI )(central venous catheters, peripheral venous catheters)
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria all blood culture positive cases
Key exclusion criteria none
Target sample size 3000

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Norio Ohmagari
Organization National Center for Global Health and Medicine
Division name Disease Control and Prevention Center
Zip code
Address 1-21-1 Toyama, Shinjyuku-ku, Tokyo
TEL 03-3202-7181
Email

Public contact
Name of contact person
1st name
Middle name
Last name Nozomi Takeshita
Organization National Center for Global Health and Medicine
Division name Disease Control and Prevention Center
Zip code
Address 1-21-1 Toyama, Shinjyuku-ku, Tokyo
TEL 03-3202-7181
Homepage URL
Email nozomitake@gmail.com

Sponsor
Institute National Center for Global Health and Medicine
Institute
Department

Funding Source
Organization none
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2012 Year 05 Month 12 Day

Related information
URL releasing protocol
Publication of results Partially published

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2012 Year 01 Month 10 Day
Date of IRB
Anticipated trial start date
2012 Year 03 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information  Hospital information: Hospital bed capacity, availability of emergency medical treatment, number of blood culture examinations (nosocomial, community-acquired)
 Clinical information: Age, sex, diagnosis, culture-positive days, information such as date antimicrobial started, department , microorganism name, date blood culture preformed, ward in which blood culture is preformed, length of hospital stay, discharge day, presence of venues catheter lines, clinical outcome, evidence of consultation with infectious disease department, etc.

Management information
Registered date
2012 Year 05 Month 12 Day
Last modified on
2013 Year 05 Month 29 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009342

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.